IL310154A - Recombinant variants of r-spondin proteins and their use - Google Patents

Recombinant variants of r-spondin proteins and their use

Info

Publication number
IL310154A
IL310154A IL310154A IL31015424A IL310154A IL 310154 A IL310154 A IL 310154A IL 310154 A IL310154 A IL 310154A IL 31015424 A IL31015424 A IL 31015424A IL 310154 A IL310154 A IL 310154A
Authority
IL
Israel
Prior art keywords
seq
variant
rspo1
domain
protein
Prior art date
Application number
IL310154A
Other languages
English (en)
Hebrew (he)
Inventor
Patrick Collombat
Paolo Botti
Original Assignee
Diogenx
Institut National De La Sant? Et De La Rech M?Dicale Inserm
Centre Nat Rech Scient
Universit? C?Te Dazur
Patrick Collombat
Paolo Botti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Diogenx, Institut National De La Sant? Et De La Rech M?Dicale Inserm, Centre Nat Rech Scient, Universit? C?Te Dazur, Patrick Collombat, Paolo Botti filed Critical Diogenx
Publication of IL310154A publication Critical patent/IL310154A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4705—Regulators; Modulating activity stimulating, promoting or activating activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
    • C07K2319/21—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a His-tag
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
IL310154A 2021-07-15 2022-07-15 Recombinant variants of r-spondin proteins and their use IL310154A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP21305993 2021-07-15
EP22305328 2022-03-18
PCT/EP2022/069925 WO2023285686A2 (en) 2021-07-15 2022-07-15 Recombinant variants of r-spondin proteins and their use

Publications (1)

Publication Number Publication Date
IL310154A true IL310154A (en) 2024-03-01

Family

ID=82799950

Family Applications (1)

Application Number Title Priority Date Filing Date
IL310154A IL310154A (en) 2021-07-15 2022-07-15 Recombinant variants of r-spondin proteins and their use

Country Status (9)

Country Link
US (2) US20240383952A1 (cg-RX-API-DMAC7.html)
EP (1) EP4370535A2 (cg-RX-API-DMAC7.html)
JP (1) JP2024526356A (cg-RX-API-DMAC7.html)
KR (1) KR20240040088A (cg-RX-API-DMAC7.html)
AU (1) AU2022311529A1 (cg-RX-API-DMAC7.html)
CA (1) CA3225626A1 (cg-RX-API-DMAC7.html)
IL (1) IL310154A (cg-RX-API-DMAC7.html)
MX (1) MX2024000757A (cg-RX-API-DMAC7.html)
WO (1) WO2023285686A2 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4087863A1 (en) * 2020-01-10 2022-11-16 Institut National de la Santé et de la Recherche Médicale (INSERM) Rspo1 proteins and their use
AU2024210262A1 (en) * 2023-01-19 2025-07-10 Centre National De La Recherche Scientifique Recombinant variants of r-spondin proteins and their use

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5179017A (en) 1980-02-25 1993-01-12 The Trustees Of Columbia University In The City Of New York Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
US4399216A (en) 1980-02-25 1983-08-16 The Trustees Of Columbia University Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
US4634665A (en) 1980-02-25 1987-01-06 The Trustees Of Columbia University In The City Of New York Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
US4751180A (en) 1985-03-28 1988-06-14 Chiron Corporation Expression using fused genes providing for protein product
US4935233A (en) 1985-12-02 1990-06-19 G. D. Searle And Company Covalently linked polypeptide cell modulators
GB8725529D0 (en) 1987-10-30 1987-12-02 Delta Biotechnology Ltd Polypeptides
US7790446B2 (en) 2005-02-11 2010-09-07 Kosagen Cell Factory Oü Vectors, cell lines and their use in obtaining extended episomal maintenance replication of hybrid plasmids and expression of gene products
US8377653B2 (en) 2005-02-11 2013-02-19 Icosagen Cell Factory Oü Viral expression plasmids for production of proteins, antibodies, enzymes, virus-like particles and for use in cell-based assays
AU2013204484B2 (en) * 2011-07-15 2016-05-12 Oncomed Pharmaceuticals, Inc. RSPO binding agents and uses thereof
WO2013049375A2 (en) * 2011-09-28 2013-04-04 The Board Of Trustees Of The Leland Stanford Junior University Methods and compositions for modulating beta cell proliferation
US9783784B2 (en) * 2013-01-04 2017-10-10 City Of Hope Methods for establishing and improving the survival of a population of pancreatic progenitor or stem cells
US9777052B2 (en) * 2014-12-02 2017-10-03 The Board Of Regents Of The University Of Oklahoma R-spondin variants, compositions, and methods of use
AU2018211985B2 (en) * 2017-01-26 2025-02-13 Surrozen Operating, Inc. Tissue-specific Wnt signal enhancing molecules and uses thereof
JP2021020900A (ja) * 2019-07-29 2021-02-18 国立大学法人北海道大学 糖代謝異常改善剤

Also Published As

Publication number Publication date
WO2023285686A3 (en) 2023-03-02
JP2024526356A (ja) 2024-07-17
KR20240040088A (ko) 2024-03-27
US20230340044A1 (en) 2023-10-26
AU2022311529A1 (en) 2024-01-25
WO2023285686A2 (en) 2023-01-19
EP4370535A2 (en) 2024-05-22
US20240383952A1 (en) 2024-11-21
MX2024000757A (es) 2024-04-18
CA3225626A1 (en) 2023-01-19

Similar Documents

Publication Publication Date Title
KR101993714B1 (ko) 대사 장애를 치료하는데 이용하기 위한 조성물과 방법
CN102143758B (zh) Fgf21突变体及其用途
AU2016346870A1 (en) Dual function proteins and pharmaceutical composition comprising same
KR20250139414A (ko) 초장기 작용 인슐린-fc 융합 단백질 및 사용 방법
WO2019119673A1 (zh) 一种双基因修饰的干细胞及其用途
JP2020506701A (ja) 組織特異的Wntシグナル増強分子およびその使用
US10562954B2 (en) Fusion protein inhibiting TACI-BAFF complex formation and preparation method therefor and use thereof
CN105837680A (zh) 治疗fgf21相关的病症的方法
EP3672621A1 (en) Glp-2 fusion polypeptides and uses for treating and preventing gastrointestinal conditions
US20230340044A1 (en) Recombinant variants of r-spondin proteins and their use
US20180280474A1 (en) Treatment of bile acid disorders
JP2026021430A (ja) Rspo1タンパク質およびその使用
AU2024210262A1 (en) Recombinant variants of r-spondin proteins and their use
JP2009521220A (ja) Bmp−7変異体組成物、方法および使用
CN115073607A (zh) Tnfr2与baff受体的融合蛋白
CN117980323A (zh) R-spondin蛋白的重组变体及其用途
JP2009544325A (ja) Bmp−7変異体組成物、方法および使用
CA3225321A1 (en) Ptprs in autoimmunity
CA2582581A1 (en) Nogo-a polypeptide fragments, variant nogo receptor-1 polypeptides, and uses thereof
KR20210082189A (ko) Glp-2 융합 폴리펩티드 및 위장 병태를 치료 및 예방하기 위한 용도